Canada markets open in 1 hour 49 minutes

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5000-0.2000 (-5.41%)
At close: 03:57PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 24.16M
Enterprise Value 9.26M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.33
Price/Book (mrq)1.79
Enterprise Value/Revenue 4.01
Enterprise Value/EBITDA -0.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 3-62.76%
S&P500 52-Week Change 3-5.12%
52 Week High 311.4800
52 Week Low 33.1900
50-Day Moving Average 34.6506
200-Day Moving Average 36.7932

Share Statistics

Avg Vol (3 month) 33.52k
Avg Vol (10 day) 35.42k
Shares Outstanding 56.31M
Implied Shares Outstanding 6N/A
Float 82.05M
% Held by Insiders 10.00%
% Held by Institutions 116.90%
Shares Short (Apr 28, 2022) 4541
Short Ratio (Apr 28, 2022) 40.12
Short % of Float (Apr 28, 2022) 4N/A
Short % of Shares Outstanding (Apr 28, 2022) 40.01%
Shares Short (prior month Mar 30, 2022) 4108

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-732.19%

Management Effectiveness

Return on Assets (ttm)-50.84%
Return on Equity (ttm)-110.15%

Income Statement

Revenue (ttm)2.47M
Revenue Per Share (ttm)0.42
Quarterly Revenue Growth (yoy)-73.60%
Gross Profit (ttm)-9.69M
EBITDA -18.17M
Net Income Avi to Common (ttm)-18.54M
Diluted EPS (ttm)-3.2460
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.89M
Total Cash Per Share (mrq)2.36
Total Debt (mrq)412.87k
Total Debt/Equity (mrq)3.19
Current Ratio (mrq)4.32
Book Value Per Share (mrq)2.05

Cash Flow Statement

Operating Cash Flow (ttm)-16.78M
Levered Free Cash Flow (ttm)-10.37M